TwinBeech Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$692K Buy
+2,645
New +$678K 0.16% 179
2025
Q3
– Sell
-57,870
Closed -$10.7M – 537
2025
Q2
$10.7M Buy
+57,870
New +$10.8M 0.24% 114
2024
Q2
– Sell
-173,088
Closed -$31.5M – 496
2024
Q1
$31.5M Buy
+173,088
New +$29.8M 0.65% 48
2022
Q1
– Sell
-26,152
Closed -$3.54M – 468
2021
Q4
$3.54M Buy
+26,152
New +$3.09M 0.2% 147
2021
Q3
– Sell
-61,358
Closed -$6.91M – 544
2021
Q2
$6.91M Buy
+61,358
New +$6.91M 0.84% 26
2020
Q4
– Sell
-46,139
Closed -$4.04M – 414
2020
Q3
$4.04M Buy
+46,139
New +$4.34M 0.88% 20

Other funds holding ABBV

TwinBeech Capital's ABBV Position: Q3 2026 in Review

TwinBeech Capital opened a new position in AbbVie (ABBV) in Q3 2026: 2,645 shares worth $692K. The stake represents 0.16% of the portfolio and ranks #179 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in ABBV as recently as Q2 2025.

TwinBeech Capital first reported a position in ABBV in Q3 2020 and has held it in 6 quarters since. The position peaked at $31.5M in Q1 2024. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • TwinBeech Capital held 2,645 shares of AbbVie worth $692K as of Q3 2026.
  • AbbVie was a new TwinBeech Capital position in Q3 2026.
  • AbbVie made up 0.16% of TwinBeech Capital's portfolio in Q3 2026, its #179 holding.
  • TwinBeech Capital first reported a position in AbbVie in Q3 2020 and has held it in 6 quarters since.
  • TwinBeech Capital's AbbVie position peaked at $31.5M in Q1 2024.
  • 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.